Quick Answer
Autonomix Medical, Inc. reported Research And Development Expense of $4.73 million for the year ending 2025.
- Autonomix Medical, Inc. showed an increase of +112.4% in Research And Development Expense from 2024 to 2025.
- This data is from Autonomix Medical, Inc.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2022: $199.0 thousand | Q2 2023: $368.0 thousand | Q3 2023: $471.0 thousand | Q4 2023: $687.0 thousand | Q2 2024: $954.0 thousand | Q3 2024: $1.17 million | Q4 2024: $1.04 million | Q2 2025: $1.59 million | Q3 2025: $2.37 million | Q4 2025: $1.72 million.
- Over the full 3 years of available data (2023 to 2025), Autonomix Medical, Inc.'s Research And Development Expense has grown by 534.2%.
- Historical annual values: Fiscal year 2025: $4.73 million | Fiscal year 2024: $2.23 million | Fiscal year 2023: $745.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: